ViewPoint Therapeutics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees

  • Latest Deal Type
  • M&A

ViewPoint Therapeutics General Information

Description

Developer of crystallin stabilizers designed to prevent and treat cataracts and presbyopia. The company's crystallin stabilizers include a small molecule that is active in preclinical models of age-related cataracts via a target-based screening and optimization effort, enabling physicians to have drugs that prevent or reverse protein misfolding, which is implicated in numerous common disorders of aging including cataracts, presbyopia, and neurodegenerative diseases.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 2388 48th Avenue
  • San Francisco, CA 94116
  • United States
Primary Industry
Drug Discovery
Corporate Office
  • 2388 48th Avenue
  • San Francisco, CA 94116
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ViewPoint Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 28-Jul-2022 Completed Generating Revenue
6. Later Stage VC 08-Nov-2019 Completed Generating Revenue
5. Early Stage VC (Series B) 05-Mar-2018 Completed Generating Revenue
4. Early Stage VC (Series A) 02-May-2016 Completed Generating Revenue
3. Grant 01-Apr-2016 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator 06-Oct-2014 Completed Generating Revenue
To view ViewPoint Therapeutics’s complete valuation and funding history, request access »

ViewPoint Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view ViewPoint Therapeutics’s complete cap table history, request access »

ViewPoint Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of crystallin stabilizers designed to prevent and treat cataracts and presbyopia. The company's crystallin sta
Drug Discovery
San Francisco, CA
11 As of 2020

Lexington, MA
 

Frederiksberg, Denmark
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ViewPoint Therapeutics Competitors (36)

One of ViewPoint Therapeutics’s 36 competitors is Voyager Therapeutics, a Formerly VC-backed company based in Lexington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Voyager Therapeutics Formerly VC-backed Lexington, MA
Muna Therapeutics Venture Capital-Backed Frederiksberg, Denmark
Alzheon Venture Capital-Backed Framingham, MA
WaveBreak Venture Capital-Backed Boston, MA
CervoMed Formerly VC-backed Boston, MA
You’re viewing 5 of 36 competitors. Get the full list »

ViewPoint Therapeutics Patents

ViewPoint Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022047315-A1 Compounds and formulations for treating ophthalmic diseases Inactive 31-Aug-2020
EP-3716981-A1 Compounds for treating near vision disorders Inactive 28-Nov-2017
US-20200276211-A1 Compounds for treating near vision disorders Inactive 28-Nov-2017
WO-2019108673-A1 Compounds for treating near vision disorders Inactive 28-Nov-2017
AU-2016321254-A1 Compounds and formulations for treating ophthalmic diseases Inactive 08-Sep-2015 A61K31/575
To view ViewPoint Therapeutics’s complete patent history, request access »

ViewPoint Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ViewPoint Therapeutics Former Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Asset Management Ventures Venture Capital Minority
BVF Partners Hedge Fund Minority
Codon Capital Venture Capital Minority
Angel (individual) Minority
Innovation Partnerships Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

ViewPoint Therapeutics FAQs

  • When was ViewPoint Therapeutics founded?

    ViewPoint Therapeutics was founded in 2014.

  • Where is ViewPoint Therapeutics headquartered?

    ViewPoint Therapeutics is headquartered in San Francisco, CA.

  • What is the size of ViewPoint Therapeutics?

    ViewPoint Therapeutics has 11 total employees.

  • What industry is ViewPoint Therapeutics in?

    ViewPoint Therapeutics’s primary industry is Drug Discovery.

  • Is ViewPoint Therapeutics a private or public company?

    ViewPoint Therapeutics is a Private company.

  • What is ViewPoint Therapeutics’s current revenue?

    The current revenue for ViewPoint Therapeutics is .

  • How much funding has ViewPoint Therapeutics raised over time?

    ViewPoint Therapeutics has raised $39M.

  • Who are ViewPoint Therapeutics’s investors?

    Asset Management Ventures, BVF Partners, Codon Capital, , and Innovation Partnerships are 5 of 16 investors who have invested in ViewPoint Therapeutics.

  • Who are ViewPoint Therapeutics’s competitors?

    Voyager Therapeutics, Muna Therapeutics, Alzheon, WaveBreak, and CervoMed are some of the 36 competitors of ViewPoint Therapeutics.

  • When was ViewPoint Therapeutics acquired?

    ViewPoint Therapeutics was acquired on 28-Jul-2022.

  • Who acquired ViewPoint Therapeutics?

    ViewPoint Therapeutics was acquired by Visus Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process